科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Pacing and clinical electrophysiology : PACE2026-09-21

Epicardial Use of Medtronic 3830 Lead in Pediatric Cardiac Resynchronization Therapy with Elevated Thresholds.

Husnu Firat Altin, Qusi Shaban, Ahmed Reyaz Lone, Shadab Wani, Olivier Ghez, Volkan Tuzcu

一句话结论 · In one sentence

Epicardial Medtronic SelectSecure 3830 lead implantation may be a feasible alternative in complex pediatric redo cases.

原始摘要(英文原文)· Original abstract
BACKGROUND: Epicardial pacing is standard in children, but conventional leads often fail due to high thresholds, fractures, or poor sensing after multiple surgeries. CASE: A 10-year-old with restrictive cardiomyopathy and prior mitral valve replacement presented with loss of capture from fractured epicardial leads. Redo sternotomy attempts with conventional leads produced thresholds up to 8.0 V. A Medtronic SelectSecure 3830 lead was implanted epicardially, achieving improved thresholds (2.7 V → 1.1 V) and stable cardiac resynchronization therapy (CRT) pacemaker function. At 2 months, thresholds and impedances remained low and stable. CONCLUSION: Epicardial Medtronic SelectSecure 3830 lead implantation may be a feasible alternative in complex pediatric redo cases.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Epicardial Use of Medtronic 3830 Lead in Pediatric Cardiac Resynchronization Therapy with Elevated Thresholds. — 科研速览 Science Skim